Europe’s fastest civil supercomputer, Jugene, was inaugurated by North Rhine-Westphalia Prime Minister Jürgen Rüttgers at the Jülich Research Centre last week.
ITI Life Sciences, Scotland’s publicly funded innovation group, is to invest a further £2 million in its programme to develop new drug discovery tools.
Thomas Geelhaar, Head of Chemicals R&D at Merck in Darmstadt, Germany, describes how the company scouts for technologies and interacts with universities.
The UK biotech sector has fallen victim to the mayhem in the capital markets. After a year of falling share prices, five quoted companies have put up “for sale” signs.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.